Kimberly Burrow, APRN
Nurse Practitioner · Henderson, KYNPI 1689976193
Payments from drug & device makers
Across 395 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$457
- Gilead$415
- Johnson & Johnson$401
- Ardelyx, Inc.$271
- plus $1K from 20 others
What the payments were for
- Food & beverage$6,469100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $1,765 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 105 | $1,713 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $457 |
| Gilead | 23 | $415 |
| Johnson & Johnson | 18 | $401 |
| Ardelyx, Inc. | 17 | $271 |
| Intercept Pharmaceuticals, Inc. | 13 | $255 |
| Madrigal Pharmaceuticals | 7 | $190 |
| Phathom Pharmaceuticals, Inc. | 11 | $148 |
| QOL Medical, LLC | 6 | $134 |
| Ironwood Pharmaceuticals, Inc | 8 | $129 |
| Organon | 9 | $108 |
| Pfizer | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Merck | 4 | $58 |
| Lilly USA, LLC | 3 | $54 |
| Fresenius Kabi USA, LLC | 3 | $50 |
| Braintree Laboratories, Inc. | 2 | $38 |
| Bristol Myers Squibb | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Amgen | 1 | $14 |
How this compares
$6,475 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 49 | $155,735 |
| OcalivaObeticholic Acid | 12 | $110,791 |
| LinzessLinaclotide | 110 | $83,637 |
| IbsrelaTenapanor Hcl | 11 | $18,294 |
| MotegrityPrucalopride Succinate | 24 | $17,799 |
| TrulancePlecanatide | 15 | $12,613 |
| NexiumEsomeprazole Magnesium | 22 | $10,996 |
| Ursodiol | 44 | $4,764 |
| Dexlansoprazole DrDexlansoprazole | 13 | $4,294 |
| Omeprazole | 362 | $2,812 |
| Colestipol Hcl | 49 | $2,585 |
| Lubiprostone | 25 | $1,990 |
| Sucralfate | 26 | $1,791 |
| Pantoprazole Sodium | 174 | $1,669 |
| Esomeprazole Magnesium | 59 | $1,515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $1,713 | $168,34864 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $255 | $110,79112 claims |
| AbbVieLinzess | $1,765 | $83,637110 claims |
| Ardelyx, Inc.Ibsrela | $271 | $18,29411 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $457 | $17,79924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Henderson
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
- Lillian ArgentEdgewood$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.